Final 5-year results of the TAXUS II trial: A randomized study to assess the effectiveness of slow-and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions

Circulation

Volumn 120, Issue 15, 2009, Pages 1498-1504

  Silber, Sigmund ^a   Colombo, Antonio ^b   Banning, Adrian P ^c   Hauptmann, Karl ^d   Drzewiecki, Janusz ^e   Grube, Eberhard ^f   Dudek, Dariusz ^g   Baim, Donald S ^h  

^a Cardiology Practice and Hospital   (Germany)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Germany)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

^f HELIOS Heart Center   (Germany)

^g JAGIELLONIAN UNIVERSITY   (Poland)

^h BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Coronary disease; Drugs; Restenosis; Stents

Indexed keywords

'TAXUS'; ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; POLYMER; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BARE METAL STENT; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SLOW RELEASE FORMULATION; STENT THROMBOSIS;

ADULT; AGED; COHORT STUDIES; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG DELIVERY SYSTEMS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; POLYMERS; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 70350125148     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.849877     Document Type: Article

References (33)

1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyn-drickx G, Emanuelsson H, Marco J, Legrand, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel MA; for the Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495. (Pubitemid 24256751)
2. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish D, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S; for the Stent Reste-nosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501. (Pubitemid 24256752)
3. Brophy JM, Bélisle P, Joseph L. Evidence for use of coronary stents: a hierarchical Bayesian meta-analysis. Ann Intern Med. 2003;138:777-786.
4. Babapulle MN, Eisenberg MJ. Coated stents for the prevention of reste-nosis: part II. Circulation. 2002;106:2859-2866.
5. Grube E, Silber S, Hauptmann KE, Müeller R, Buellesfeld L, Gerckens U, Russell ME. TAXUS I six-and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003;107:38-42.
6. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME; for the TAXUS II Study Group. Randomized study to assess the effectiveness of slow-and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003;108:788-794.
7. Serruys PW, Degertekin M, Tanabe K, Russell ME, Guagliumi G, Webb J, Hamburger J, Rutsch W, Kaiser C, Whitbourn R, Camenzind E, Meredith I, Reeves F, Nienaber C, Benit E, Disco C, Koglin J, Colombo A; for the TAXUS II Study Group. Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial. Circulation. 2004;109:627-633.
8. Silber S, Hamburger J, Grube E, Pfisterer M, Belardi J, Webb J, Zmudka K, Nienaber C, Hauptman K, Rutsch W, Dawkins K, Drzewiecki J, Koglin J, Colombo A. Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation: a post hoc analysis of TAXUS II. Herz. 2004;29:171-180.
9. Tanabe K, Serruys PW, Degertekin M, Guagliumi G, Grube E, Chan C, Munzel T, Belardi J, Ruzyllo W, Bilodeau L, Kelbæk H, Ormiston J, Dawkins K, Roy L, Strauss BH, Disco C, Koglin J, Russell ME; for the TAXUS II Study Group. Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial. Circulation. 2004;109:196-200.
10. Tanabe K, Serruys PW, Degertekin Grube E, Guagliumi G, Urbaszek W, Bonnier J, Lablanche JM, Siminiak T, Nordrehaug J, Figulla H, Drze-wiecki J, Banning A, Hauptmann K, Dudek D, Bruining N, Hamers R, Hoye A, Ligthart JMR, Disco C, Koglin J, Russell ME, Colombo A; for the TAXUS II Study Group. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation. 2005;111:900-905.
11. Aoki J, Colombo A, Dudek D, Banning AP, Drzewiecki J, Zmudka K, Schiele F, Russell ME, Koglin J, Serruys PW; for the TAXUS II Study Group. Persistent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation. 2005;112:3876-3883.
12. Tsuchida K, Serruys PW, Bruining N, Dudek D, Drzewiecki J, Banning AP, Zmudka K, Schiele F, Zhou Z, Rademaker TAM, van Es GA, Koglin J, Russell ME, Colombo A. Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial. Am J Cardiol. 2007;99:607-615.
13. Stone GW, Ellis SG, Colombo A, Dawkins KD, Grube E, Cutlip DE, Friedman M, Baim DS, Koglin J. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation. Circulation. 2007; 115:2842-2847.
14. Stone GW, Ellis SG, Colombo A, Grube E, Dawkins KD, Friedman M, Baim DS. Effect of prolonged thienopyridine use after drug-eluting stent implantation (from the TAXUS landmark trials data). Am J Cardiol. 2008;102:1017-1022.
15. Ellis SG, O'Shaughnessy CD, Martin SL, Kent K, McGarry T, Turco MA, Kereiakes DJ, Popma JJ, Friedman M, Koglin J, Stone GW; for the TAXUS V ISR Investigators. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. Eur Heart J. 2008;29:1625-1634.
16. Lasala JM, Cox DA, Dobbies D, Muhlestein JB, Katopodis JN, Revtyak G, Baim DS; for the ARRIVE 1 participating physicians. Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registry. Catheter Cardiovasc Interv. 2008;72:433-445.
17. Grube E, Silber S, Hauptmann KE, Buellesfeld L, Müeller R, Lim V, Gerckens U, Russell ME. Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I). Am J Cardiol. 2005; 96:79-82.
18. Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J. 2006;27:2784-2814.
19. Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation. 2007;115:1440-1455.
20. Grube E, Dawkins KD, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Buellesfeld L, Koglin J, Russell ME. TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting stents with bare metal stents for treatment of long, complex lesion. Eur Heart J. 2007;28:2578-2582.
21. Krucoff MW, Kereiakes DJ, Petersen JL, Mehran R, Hasselblad V, Lansky AJ, Fitzgerald PJ, Garg J, Turco MA, Simonton CA III, Verheye S, Dubois CL, Gammon R, Batchelor WB, O'Shaughnessy CD, Hermiller JB Jr, Schofer J, Buchbinder M, Wijns W. A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study. J Am Coll Cardiol. 2008;51:1543-1552.
22. Silber S, Borggrefe M, Böhm M, Hoffmeister HM, Dietz R, Ertl G, Heusch G. Drug-eluting stents (DES) and drug-eluting balloons (DEB): position paper of the German Society of Cardiology. Clin Res Cardiol. 2008;97:548-563.
23. Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, Lee CW, Choi D, Jang Y, Lam R, Weissman NJ, Mintz GS. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med. 2003;348: 1537-1545. (Pubitemid 36437930)
24. Park DW, Hong MK, Mintz GS, Lee CW, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Weissman NJ, Park SW, Park SJ. Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study. J Am Coll Cardiol. 2006;48:2432-2439.
25. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356:989-997.
26. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB. Safety and efficacy of sirolimus-and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998-1008.
27. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbæk H, Menichelli D, Sabaté M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schömig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356:1030-1039.
28. King SB III, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2007 Writing Group to Review New Evidence and Update the 2005 ACC/AHA/SCAI Guideline Update for Percutaneous Coronary Intervention). Circulation. 2008;117:261-295.
29. Wenaweser P, Rey C, Eberli FR, Togni M, Tuller D, Locher S, Remondino A, Seiler C, Hess OM, Meier B, Windecker S. Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart J. 2005;26:1180-1187.
30. Saito T, Asajima H. Recurrent very late stent thrombosis after bare-metal stent implantation. Catheter Cardiovasc Interv. 2007;70:51-53.
31. Mauri L, Hsieh WH, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020-1029.
32. Kirtane AJ, Stone G. Comprehensive meta-analysis of DES vs BMS randomized trials and registries. Presented at: American College of Cardiology 57th Annual Scientific Session; Chicago, Ill; March 2008.
33. Rastan AJ, Boudriot E, Falk V, Kappetein AP, Borger MA, Serruys PW, Schuler G, Mohr FW. Frequency and pattern of de-novo three-vessel and left main coronary artery disease: insights from single center enrolment in the SYNTAX study. Eur J Cardiothorac Surg. 2008;34:376-382.